Literature DB >> 26902622

Female Sexual Dysfunction: Is It a Treatable Disease?

Justin Houman1, Tom Feng1, Karyn S Eilber1, Jennifer T Anger2.   

Abstract

Female sexual dysfunction affects approximately 40% of women (Sexual problems and distress in United States women: prevalence and correlates; Shifren et al., Obstet Gynecol, 112(5): 970-978, 2008). Due to its multi-factorial etiology, a wide variety of treatments are available that address specific symptoms, but no treatment exists that treats the overall disorder. Significant strides have recently been made in an effort to treat the plethora of symptoms associated with this disorder. The purpose of this article is to provide an overview of recent research on the available treatments for female sexual dysfunction. We discuss novel agents such as flibanserin, as well as various mechanical devices and hormonal treatments aimed at the specific subtypes of female sexual dysfunction.

Entities:  

Keywords:  Female sexual dysfunction; Female urology; Flibanserin; Treatment

Mesh:

Substances:

Year:  2016        PMID: 26902622     DOI: 10.1007/s11934-016-0583-5

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  33 in total

1.  Effect of long-term intranasal oxytocin on sexual dysfunction in premenopausal and postmenopausal women: a randomized trial.

Authors:  Dana A Muin; Michael Wolzt; Rodrig Marculescu; Safoura Sheikh Rezaei; Mohamed Salama; Carola Fuchs; Anton Luger; Elia Bragagna; Brigitte Litschauer; Michaela Bayerle-Eder
Journal:  Fertil Steril       Date:  2015-07-04       Impact factor: 7.329

2.  Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.

Authors:  Susan R Davis; M J van der Mooren; Rik H W van Lunsen; Patrice Lopes; Claude Ribot; Jean Ribot; Margaret Rees; Alain Moufarege; Cynthia Rodenberg; Akshay Buch; David W Purdie
Journal:  Menopause       Date:  2006 May-Jun       Impact factor: 2.953

3.  Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study.

Authors:  Leonard R Derogatis; Lawrence Komer; Molly Katz; Michèle Moreau; Toshio Kimura; Miguel Garcia; Glen Wunderlich; Robert Pyke
Journal:  J Sex Med       Date:  2012-01-16       Impact factor: 3.802

4.  Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.

Authors:  James Simon; Glenn Braunstein; Lila Nachtigall; Wulf Utian; Molly Katz; Sam Miller; Arthur Waldbaum; Celine Bouchard; Christine Derzko; Akshay Buch; Cynthia Rodenberg; Johna Lucas; Susan Davis
Journal:  J Clin Endocrinol Metab       Date:  2005-07-12       Impact factor: 5.958

5.  Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial.

Authors:  John E Buster; Sheryl A Kingsberg; Oscar Aguirre; Candace Brown; Jeffrey G Breaux; Akshay Buch; Cynthia A Rodenberg; Kathryn Wekselman; Peter Casson
Journal:  Obstet Gynecol       Date:  2005-05       Impact factor: 7.661

6.  Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study.

Authors:  I Persson; H O Adami; L Bergkvist; A Lindgren; B Pettersson; R Hoover; C Schairer
Journal:  BMJ       Date:  1989-01-21

7.  Effects of sacral neuromodulation on female sexual function.

Authors:  Rachel N Pauls; Serge P Marinkovic; W Andre Silva; Christopher M Rooney; Steven D Kleeman; Mickey M Karram
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-07-26

Review 8.  The role of mechanical devices in treating female sexual dysfunction and enhancing the female sexual response.

Authors:  Kevin L Billups
Journal:  World J Urol       Date:  2002-05-15       Impact factor: 4.226

9.  Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study.

Authors:  Jennifer R Berman; Laura A Berman; Steven M Toler; Jennifer Gill; Scott Haughie
Journal:  J Urol       Date:  2003-12       Impact factor: 7.450

10.  Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women.

Authors:  Fernand Labrie; David Archer; Céline Bouchard; Michel Fortier; Leonello Cusan; José-Luis Gomez; Ginette Girard; Mira Baron; Normand Ayotte; Michèle Moreau; Robert Dubé; Isabelle Côté; Claude Labrie; Lyne Lavoie; Louise Berger; Lucy Gilbert; Céline Martel; John Balser
Journal:  Menopause       Date:  2009 Sep-Oct       Impact factor: 2.953

View more
  2 in total

1.  When sex meets age: Family physicians' perspectives about sexual dysfunction among older men and women: A qualitative study from Israel.

Authors:  Inbar Levkovich; Ateret Gewirtz-Meydan; Khaled Karkabi; Liat Ayalon
Journal:  Eur J Gen Pract       Date:  2019-03-08       Impact factor: 1.904

Review 2.  Female sexual dysfunction: a focus on flibanserin.

Authors:  Nicole M Lodise
Journal:  Int J Womens Health       Date:  2017-10-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.